Cargando…

Population based germline testing for primary cancer prevention

Detalles Bibliográficos
Autores principales:	Manchanda, Ranjit, Legood, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145693/ https://www.ncbi.nlm.nih.gov/pubmed/30237851 http://dx.doi.org/10.18632/oncotarget.25995

Ejemplares similares

Population‐based genetic testing for cancer susceptibility genes: quo vadis?
por: Manchanda, Ranjit, et al.
Publicado: (2022)

Population Based Testing for Primary Prevention: A Systematic Review
por: Manchanda, Ranjit, et al.
Publicado: (2018)

Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control
por: Sun, Li, et al.
Publicado: (2022)

Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China
por: Sun, Li, et al.
Publicado: (2022)

Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review
por: Oxley, Samuel, et al.
Publicado: (2022)

Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review
por: Wei, Xia, et al.
Publicado: (2022)

Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer
por: Esplin, Edward D., et al.
Publicado: (2022)

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
por: Gaba, Faiza, et al.
Publicado: (2023)

Germline polymorphisms as modulators of cancer phenotypes
por: Tan, Patrick
Publicado: (2008)

Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
por: Chandrasekaran, Dhivya, et al.
Publicado: (2021)

Looking beyond the Lamppost: Population-Level Primary Prevention of Breast Cancer
por: McLoughlin, Gabriella M., et al.
Publicado: (2020)

Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews
por: Gaba, Faiza, et al.
Publicado: (2022)

Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
por: Burnell, Matthew, et al.
Publicado: (2022)

Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
por: Manchanda, Ranjit, et al.
Publicado: (2020)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations—A Social Epidemiology Counterargument
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2020)

Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention
por: Gaba, Faiza, et al.
Publicado: (2020)

Diabetes predisposition inherited through maternal germline
por: Zhu, Hong, et al.
Publicado: (2022)

Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Pennington, Mark, et al.
Publicado: (2016)

Report from an NCI Roundtable: Cancer Prevention in Primary Care
por: Samimi, Goli, et al.
Publicado: (2022)

Human germline editing: Insights to future clinical treatment of diseases
por: Li, Yanni, et al.
Publicado: (2018)

Translational activation maintains germline tissue homeostasis during adulthood
por: Nousch, Marco, et al.
Publicado: (2015)

Beyond Genes: Germline Disruption in the Etiology of Autism Spectrum Disorders
por: Escher, Jill, et al.
Publicado: (2021)

The Continued Absence of Functional Germline Stem Cells in Adult Ovaries
por: Yoshihara, Masahito, et al.
Publicado: (2022)

Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology
por: Dixon, Katherine, et al.
Publicado: (2020)

Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”
por: Manchanda, Ranjit
Publicado: (2022)

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
por: Sun, Li, et al.
Publicado: (2019)

PAR-5 is a PARty hub in the germline: Multitask proteins in development and disease
por: Aristizábal-Corrales, David, et al.
Publicado: (2013)

IL‐7 germline variant: setting the stage for immune‐related adverse events
por: Issaoui, Hussein, et al.
Publicado: (2023)

First clinical study of germline-targeting strategy: One step closer to a successful bnAb-based HIV vaccine
por: Sun, Caijun, et al.
Publicado: (2023)

Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?
por: Tralongo, Antonino C., et al.
Publicado: (2021)

Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer
por: Fitzgerald, Paul J
Publicado: (2010)

Prevention of psychosis: moving on from the at-risk mental state to universal primary prevention
por: Murray, Robin M., et al.
Publicado: (2021)

Obesity in primary care: prevention, management and the paradox
por: Haslam, David
Publicado: (2014)

Speeding the growth of primary mental health prevention
por: Wissow, Lawrence S
Publicado: (2015)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Access to preventive care by immigrant populations
por: Harris, Mark Fort
Publicado: (2012)

Recommendations and Future Direction for Population-Based Prevention and Control of Behavioral Risk Factors for NCDs
por: Wang, Zhuoqun, et al.
Publicado: (2022)

Long-Term Realism and Cost-Effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide
por: Bray, Freddie, et al.
Publicado: (2015)

Advancing Cancer Prevention Practice Facilitation Work in Rural Primary Care During COVID-19
por: Boatman, Dannell, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v72pafkfac6lgsi3u7gp6dn2l8